Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
425 INR | +0.01% | +2.68% | +4.93% |
30/04 | Granules Pharmaceuticals Arm Gets US FDA's Approval for Generic Drug for Gout Flares | MT |
15/04 | Granules India Gets Zero Observation from US FDA After Inspection of Visakhapatnam, India Unit | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.93% | 1.23B | |
+29.68% | 681B | |
+20.01% | 556B | |
-4.35% | 361B | |
+17.65% | 325B | |
+3.77% | 285B | |
+13.55% | 235B | |
+4.54% | 199B | |
-12.23% | 189B | |
-3.79% | 157B |
- Stock Market
- Equities
- GRANULES Stock
- News Granules India Limited
- Granules India : Board to Consider Interim Dividend for Fiscal 2022